CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN

CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN was reported 2534 times

CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 KERATECTOMY 1 0.1667
1 CONTACT LENS THERAPY 1 0.1667
2 LIP LESION EXCISION 1 0.1429
3 LID MARGIN DISCHARGE 2 0.0741
4 SCLERAL HYPERAEMIA 45 0.0661
5 CORNEAL LACERATION 1 0.0556
6 FAECAL ELASTASE CONCENTRATION ABNORMAL 1 0.0556
7 INSTILLATION SITE COMPLICATION 1 0.0476
8 KIDNEY ABLATION 1 0.0455
9 INSTILLATION SITE HYPERSENSITIVITY 1 0.0435
10 ARTIFICIAL HEART IMPLANT 1 0.0417
11 DONOR LEUKOCYTE INFUSION 1 0.0385
12 BRAIN STENT INSERTION 1 0.0357
13 LASER SURGERY 1 0.0357
14 GLAUCOMA DRAINAGE DEVICE PLACEMENT 2 0.0345
15 KERATOMILEUSIS 6 0.0233
16 INSTILLATION SITE FOREIGN BODY SENSATION 3 0.0207
17 BENIGN NEOPLASM OF EYE 1 0.0200
18 INFUSION SITE EXFOLIATION 1 0.0192
19 PRODUCT CONTAINER ISSUE 163 0.0190
20 EYE ABRASION 1 0.0189
21 CAROTID ARTERIAL EMBOLUS 1 0.0189
22 SWOLLEN TEAR DUCT 2 0.0189
23 CONJUNCTIVAL BLEB 1 0.0185
24 EYELASH CHANGES 3 0.0169
25 CONTAMINATED PRODUCT ADMINISTERED 1 0.0164
26 FOREIGN BODY SENSATION IN EYES 104 0.0163
27 GRAFT VERSUS HOST DISEASE ORAL 1 0.0156
28 INSTILLATION SITE PAIN 38 0.0153
29 EYELID SENSORY DISORDER 3 0.0152
30 INSTILLATION SITE DISCOMFORT 2 0.0149
31 EYE COMPLICATION ASSOCIATED WITH DEVICE 4 0.0149
32 OCULAR ROSACEA 3 0.0148
33 EYELID PAIN 29 0.0143
34 REACTION TO PRESERVATIVES 11 0.0135
35 CARDIAC STEATOSIS 1 0.0135
36 MEIBOMIAN GLAND DYSFUNCTION 6 0.0132
37 PERIORBITAL PAIN 11 0.0130
38 ABNORMAL SENSATION IN EYE 55 0.0128
39 PRODUCT INFORMATION CONTENT COMPLAINT 3 0.0108
40 LACRIMATION DECREASED 5 0.0105
41 FOREIGN BODY IN EYE 10 0.0104
42 EYE DISCHARGE 108 0.0104
43 EYELID EXFOLIATION 8 0.0101
44 INTRAOCULAR LENS IMPLANT 5 0.0101
45 NONINFECTIVE CONJUNCTIVITIS 1 0.0100
46 EYELID IRRITATION 24 0.0096
47 CATHETER SITE INJURY 2 0.0094
48 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
49 CORNEAL TRANSPLANT 7 0.0089
50 EYE IRRITATION 492 0.0085
51 BILIRUBIN URINE PRESENT 1 0.0084
52 BURKHOLDERIA TEST POSITIVE 1 0.0081
53 CATARACT OPERATION COMPLICATION 4 0.0079
54 BLOOD GASTRIN INCREASED 1 0.0078
55 EYE OPERATION 36 0.0078
56 CORNEAL EROSION 4 0.0074
57 OCULAR STROKE 1 0.0072
58 RETINAL OPERATION 2 0.0072
59 CARCINOID TUMOUR OF THE STOMACH 1 0.0071
60 CYSTIC LUNG DISEASE 1 0.0070
61 EPENDYMOMA 1 0.0069
62 HYPERACTIVE PHARYNGEAL REFLEX 1 0.0069
63 EYELIDS PRURITUS 21 0.0067
64 MEDICAL DEVICE SITE DISCHARGE 1 0.0065
65 BLOOD INSULIN DECREASED 1 0.0065
66 OCULAR DISCOMFORT 72 0.0064
67 SUPERFICIAL INJURY OF EYE 7 0.0064
68 EYE DEGENERATIVE DISORDER 1 0.0060
69 BLEPHARAL PIGMENTATION 3 0.0059
70 EYE PAIN 331 0.0059
71 CONJUNCTIVITIS BACTERIAL 2 0.0058
72 INJURY CORNEAL 3 0.0058
73 INSTILLATION SITE SWELLING 1 0.0057
74 INSTILLATION SITE ERYTHEMA 3 0.0057
75 GLASSY EYES 4 0.0056
76 ERYTHEMA OF EYELID 30 0.0055
77 EYELID MARGIN CRUSTING 16 0.0055
78 INSTILLATION SITE PRURITUS 2 0.0053
79 OCULAR PROCEDURAL COMPLICATION 1 0.0052
80 DEAFNESS PERMANENT 1 0.0051
81 IRIS HYPERPIGMENTATION 1 0.0048
82 MICROGRAPHIC SKIN SURGERY 1 0.0047
83 LASER THERAPY 1 0.0044
84 BREAST HAEMATOMA 1 0.0044
85 ASTHENOPIA 24 0.0044
86 OCULAR HYPERAEMIA 200 0.0042
87 CORNEAL DEGENERATION 1 0.0041
88 CORNEAL NEOVASCULARISATION 1 0.0040
89 BURNING FEET SYNDROME 1 0.0040
90 CHRONIC DISEASE 1 0.0039
91 DRAIN PLACEMENT 1 0.0039
92 BREAST DISORDER FEMALE 1 0.0039
93 PRODUCT DROPPER ISSUE 3 0.0038
94 DRY EYE 190 0.0038
95 NEOVASCULARISATION 1 0.0038
96 CHOLANGITIS INFECTIVE 1 0.0038
97 EYELID OPERATION 1 0.0037
98 DEPOSIT EYE 1 0.0037
99 CATHETERISATION CARDIAC ABNORMAL 1 0.0037
100 CUTIS LAXA 1 0.0037
101 CORNEAL ABRASION 5 0.0036
102 CHEMICAL BURNS OF EYE 1 0.0036
103 MULTIPLE USE OF SINGLE-USE PRODUCT 20 0.0036
104 LENS DISORDER 1 0.0035
105 HORDEOLUM 15 0.0035
106 ENDOCRINE OPHTHALMOPATHY 3 0.0035
107 PRODUCT CONTAINER SEAL ISSUE 6 0.0034
108 HYPOAESTHESIA EYE 2 0.0034
109 EYE LASER SURGERY 2 0.0034
110 EYE INJURY 10 0.0033
111 ALLERGY TO VACCINE 1 0.0032
112 FEAR OF EATING 1 0.0032
113 BREAST CELLULITIS 1 0.0032
114 MEDICATION RESIDUE PRESENT 15 0.0031
115 CHALAZION 2 0.0031
116 DACRYOSTENOSIS ACQUIRED 4 0.0031
117 CATARACT 183 0.0031
118 METABOLIC FUNCTION TEST ABNORMAL 1 0.0030
119 EYE PRURITUS 102 0.0030
120 BREAST HAEMORRHAGE 1 0.0030
121 PRODUCT DELIVERY MECHANISM ISSUE 16 0.0030
122 SUSPECTED PRODUCT CONTAMINATION 3 0.0030
123 ACQUIRED OESOPHAGEAL WEB 1 0.0029
124 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 4 0.0029
125 BREAST HYPERPLASIA 1 0.0028
126 INTRAOCULAR PRESSURE TEST ABNORMAL 2 0.0028
127 EYELID OEDEMA 33 0.0028
128 IDIOPATHIC INTERSTITIAL PNEUMONIA 1 0.0028
129 LACRIMATION INCREASED 85 0.0028
130 PRODUCT DESIGN ISSUE 2 0.0028
131 PRODUCT USE COMPLAINT 44 0.0028
132 INFUSION SITE MASS 3 0.0028
133 INSTILLATION SITE REACTION 3 0.0028
134 HYPERPARATHYROIDISM PRIMARY 1 0.0027
135 PHOTOPHOBIA 51 0.0027
136 EXCESSIVE EYE BLINKING 4 0.0027
137 CORNEAL DEPOSITS 2 0.0027
138 CORNEAL REFLEX DECREASED 1 0.0027
139 CONJUNCTIVAL DISORDER 1 0.0026
140 LIPID METABOLISM DISORDER 1 0.0026
141 MACULAR DEGENERATION 31 0.0026
142 EYELID FUNCTION DISORDER 2 0.0025
143 PHYSICAL PRODUCT LABEL ISSUE 3 0.0025
144 ALTERED VISUAL DEPTH PERCEPTION 2 0.0024
145 FAECAL CALPROTECTIN ABNORMAL 1 0.0024
146 CORNEAL DYSTROPHY 1 0.0024
147 ABDOMINAL CAVITY DRAINAGE 1 0.0024
148 BILIARY OBSTRUCTION 3 0.0023
149 EYELID INFECTION 1 0.0023
150 DEGENERATIVE BONE DISEASE 1 0.0023
151 PRODUCT CONTAMINATION 8 0.0022
152 ALLERGY TO ARTHROPOD STING 1 0.0022
153 ALLERGY TO PLANTS 1 0.0022
154 INFUSION SITE RASH 3 0.0022
155 BLOOD CHROMOGRANIN A INCREASED 1 0.0022
156 ANGIOSARCOMA 1 0.0022
157 EYE DISORDER 70 0.0021
158 BLOOD CHOLESTEROL 1 0.0021
159 EYE INFECTION 23 0.0020
160 BLADDER MASS 1 0.0020
161 BLEPHARITIS 8 0.0020
162 CORNEAL SCAR 1 0.0020
163 VISION BLURRED 268 0.0019
164 ACCIDENT AT HOME 1 0.0019
165 EYE ALLERGY 3 0.0019
166 INFUSION SITE DISCOMFORT 2 0.0019
167 INTRAOCULAR PRESSURE DECREASED 1 0.0019
168 EYE CONTUSION 4 0.0019
169 IRIS DISORDER 1 0.0019
170 MILK ALLERGY 1 0.0018
171 DRY AGE-RELATED MACULAR DEGENERATION 2 0.0018
172 EYE INFECTION BACTERIAL 1 0.0018
173 ESSENTIAL TREMOR 2 0.0018
174 ECZEMA EYELIDS 1 0.0018
175 LIQUID PRODUCT PHYSICAL ISSUE 13 0.0018
176 SWELLING OF EYELID 11 0.0018
177 TREATMENT DELAYED 3 0.0017
178 VITREOUS FLOATERS 17 0.0017
179 LACRIMAL DISORDER 1 0.0017
180 EYE BURNS 1 0.0017
181 EYE SWELLING 63 0.0017
182 INSTILLATION SITE IRRITATION 2 0.0017
183 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
184 MEAN PLATELET VOLUME INCREASED 1 0.0017
185 EYELID SKIN DRYNESS 2 0.0016
186 KERATITIS 5 0.0016
187 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 1 0.0016
188 RETINAL TEAR 4 0.0016
189 LOWER EXTREMITY MASS 1 0.0016
190 PERIORBITAL SWELLING 9 0.0016
191 MITRAL VALVE CALCIFICATION 1 0.0016
192 STOMA SITE INFECTION 2 0.0015
193 EXPIRED PRODUCT ADMINISTERED 51 0.0015
194 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
195 HERPES OPHTHALMIC 2 0.0015
196 MACULAR FIBROSIS 1 0.0015
197 EYELID PTOSIS 15 0.0015
198 SKIN WRINKLING 4 0.0015
199 GENITAL SWELLING 1 0.0014
200 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
201 FACIAL DISCOMFORT 1 0.0014
202 GLAUCOMA 27 0.0014
203 LARYNGEAL DISORDER 1 0.0014
204 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
205 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
206 CONJUNCTIVITIS ALLERGIC 2 0.0013
207 ASTIGMATISM 2 0.0013
208 CHROMATOPSIA 1 0.0013
209 READING DISORDER 3 0.0013
210 GASTROINTESTINAL SURGERY 1 0.0013
211 GROWTH OF EYELASHES 1 0.0013
212 EYE INFLAMMATION 12 0.0013
213 NIGHT BLINDNESS 2 0.0012
214 CYSTITIS INTERSTITIAL 2 0.0012
215 INTERVERTEBRAL DISC SPACE NARROWING 1 0.0012
216 FEAR OF FALLING 1 0.0012
217 PRODUCT LABEL ISSUE 8 0.0012
218 RETINAL DISORDER 3 0.0012
219 POOR QUALITY PRODUCT ADMINISTERED 12 0.0011
220 INFUSION SITE DISCOLOURATION 1 0.0011
221 ANIMAL BITE 3 0.0011
222 HAEMOGLOBIN INCREASED 5 0.0011
223 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
224 PRODUCT PACKAGING ISSUE 10 0.0011
225 ARNOLD-CHIARI MALFORMATION 1 0.0010
226 CANCER SURGERY 1 0.0010
227 COLON NEOPLASM 1 0.0010
228 BONE SWELLING 1 0.0010
229 CORRECTIVE LENS USER 1 0.0010
230 NEUROENDOCRINE CARCINOMA OF THE SKIN 1 0.0010
231 MULTIPLE ALLERGIES 8 0.0010
232 DUST ALLERGY 1 0.0010
233 INTRAOCULAR PRESSURE INCREASED 13 0.0010
234 DEVICE RELATED THROMBOSIS 1 0.0010
235 HEMIANOPIA 1 0.0010
236 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
237 EYE COLOUR CHANGE 1 0.0010
238 CAROTID ARTERIOSCLEROSIS 1 0.0010
239 INFUSION SITE PRURITUS 3 0.0009
240 BLINDNESS TRANSIENT 7 0.0009
241 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 1 0.0009
242 CORNEAL DISORDER 2 0.0009
243 INFUSION SITE HAEMORRHAGE 3 0.0009
244 PRODUCT LOT NUMBER ISSUE 2 0.0009
245 HALO VISION 1 0.0009
246 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
247 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
248 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
249 EYELID DISORDER 2 0.0009
250 MADAROSIS 10 0.0009
251 LIP ULCERATION 1 0.0009
252 INGROWING NAIL 2 0.0008
253 VISUAL ACUITY REDUCED 28 0.0008
254 MYOPIA 2 0.0008
255 COLON OPERATION 1 0.0008
256 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
257 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
258 PHOTOPSIA 5 0.0008
259 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
260 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
261 LEFT ATRIAL DILATATION 1 0.0008
262 HEPATIC INFECTION 1 0.0008
263 PERIORBITAL OEDEMA 4 0.0008
264 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
265 PRODUCT FORMULATION ISSUE 5 0.0008
266 ACROCHORDON 1 0.0008
267 BLOOD POTASSIUM ABNORMAL 2 0.0007
268 PRODUCT RESIDUE PRESENT 4 0.0007
269 STOMA SITE DISCHARGE 2 0.0007
270 ULCERATIVE KERATITIS 2 0.0007
271 IMMUNOGLOBULINS DECREASED 1 0.0007
272 DISCHARGE 1 0.0007
273 CHRONIC FATIGUE SYNDROME 1 0.0007
274 ELECTRIC SHOCK SENSATION 2 0.0007
275 NEUROENDOCRINE TUMOUR 1 0.0007
276 GLUTEN SENSITIVITY 1 0.0007
277 VISUAL IMPAIRMENT 86 0.0007
278 OCULAR ICTERUS 3 0.0007
279 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
280 PULMONARY PAIN 2 0.0007
281 STRABISMUS 2 0.0007
282 DARK CIRCLES UNDER EYES 1 0.0007
283 CATARACT OPERATION 4 0.0007
284 GASTROINTESTINAL WALL THICKENING 1 0.0007
285 MENTAL FATIGUE 1 0.0007
286 MOUTH INJURY 1 0.0007
287 AGE-RELATED MACULAR DEGENERATION 1 0.0007
288 INTELLECTUAL DISABILITY 1 0.0007
289 ROSACEA 3 0.0006
290 INFUSION SITE EXTRAVASATION 4 0.0006
291 UMBILICAL HERNIA 3 0.0006
292 MEDICAL DEVICE IMPLANTATION 1 0.0006
293 INFUSION SITE SWELLING 4 0.0006
294 KERATOPATHY 1 0.0006
295 INTESTINAL OPERATION 1 0.0006
296 INHIBITORY DRUG INTERACTION 1 0.0006
297 LIMB OPERATION 3 0.0006
298 SKIN EROSION 2 0.0006
299 COLON CANCER METASTATIC 1 0.0006
300 INCORRECT PRODUCT STORAGE 8 0.0006
301 DIABETIC NEUROPATHY 3 0.0006
302 MEDICAL PROCEDURE 1 0.0006
303 ARTHROPOD STING 1 0.0006
304 GASTRIC DILATATION 1 0.0006
305 EYE HAEMORRHAGE 8 0.0006
306 NEPHRITIS 2 0.0006
307 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
308 CONJUNCTIVITIS 11 0.0006
309 WRONG PRODUCT ADMINISTERED 4 0.0006
310 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
311 INCORRECT STORAGE OF DRUG 1 0.0006
312 DIPLOPIA 15 0.0006
313 ARTHRITIS 45 0.0006
314 BLINDNESS UNILATERAL 8 0.0006
315 BREAST CYST 1 0.0006
316 MITRAL VALVE DISEASE 1 0.0006
317 CONJUNCTIVAL HYPERAEMIA 2 0.0006
318 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
319 DEVICE ALARM ISSUE 1 0.0006
320 PRODUCT ADMINISTRATION ERROR 11 0.0005
321 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
322 LYMPH NODE PAIN 1 0.0005
323 HYPERACUSIS 2 0.0005
324 PARANASAL SINUS DISCOMFORT 2 0.0005
325 ARTERIAL DISORDER 1 0.0005
326 OESOPHAGEAL DISORDER 2 0.0005
327 FOOD ALLERGY 4 0.0005
328 PRODUCT LABEL CONFUSION 3 0.0005
329 HYPOGEUSIA 1 0.0005
330 NASAL DISCOMFORT 4 0.0005
331 LARGE INTESTINAL STENOSIS 1 0.0005
332 SEASONAL ALLERGY 7 0.0005
333 EAR HAEMORRHAGE 1 0.0005
334 BLINDNESS 20 0.0005
335 DIVERTICULAR PERFORATION 1 0.0005
336 SPINAL STENOSIS 2 0.0005
337 CHEST INJURY 1 0.0005
338 LIVEDO RETICULARIS 1 0.0005
339 PRODUCT ODOUR ABNORMAL 5 0.0005
340 EAR SWELLING 1 0.0005
341 PRODUCT DISPENSING ISSUE 2 0.0005
342 HYPERPHOSPHATAEMIA 1 0.0005
343 INFUSION SITE BRUISING 1 0.0005
344 TONGUE DISCOLOURATION 2 0.0005
345 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
346 ENDOMETRIAL CANCER 1 0.0005
347 GRIP STRENGTH DECREASED 4 0.0005
348 WHEELCHAIR USER 2 0.0004
349 APPLICATION SITE URTICARIA 1 0.0004
350 CHRONIC GASTRITIS 1 0.0004
351 OROPHARYNGEAL DISCOMFORT 4 0.0004
352 BLOOD LOSS ANAEMIA 1 0.0004
353 HAEMATOCRIT INCREASED 1 0.0004
354 DERMATITIS CONTACT 5 0.0004
355 CYTOMEGALOVIRUS COLITIS 1 0.0004
356 NECK SURGERY 1 0.0004
357 THERMAL BURN 3 0.0004
358 THERAPEUTIC RESPONSE DECREASED 25 0.0004
359 BRONCHITIS CHRONIC 1 0.0004
360 EYE OEDEMA 1 0.0004
361 ACUTE PSYCHOSIS 1 0.0004
362 FOOT OPERATION 2 0.0004
363 EXPIRED DRUG ADMINISTERED 2 0.0004
364 CANCER PAIN 1 0.0004
365 MEAN CELL VOLUME INCREASED 1 0.0004
366 CONCUSSION 3 0.0004
367 PELVIC FRACTURE 3 0.0004
368 HERNIA REPAIR 1 0.0004
369 ACCIDENTAL OVERDOSE 14 0.0004
370 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
371 TOOTH INFECTION 5 0.0004
372 GASTROINTESTINAL STROMAL TUMOUR 1 0.0004
373 FOOD POISONING 2 0.0004
374 ABDOMINAL MASS 1 0.0004
375 BREAST SWELLING 1 0.0004
376 SINUS CONGESTION 5 0.0004
377 HIP SURGERY 2 0.0004
378 PRODUCT DISPENSING ERROR 8 0.0004
379 LIP BLISTER 1 0.0004
380 BLOOD PHOSPHORUS INCREASED 1 0.0004
381 DIVERTICULITIS 10 0.0004
382 CARPAL TUNNEL SYNDROME 5 0.0004
383 PRODUCT LEAKAGE 2 0.0004
384 INFUSION SITE ERYTHEMA 3 0.0004
385 SKIN HYPERPIGMENTATION 3 0.0003
386 LIP PAIN 1 0.0003
387 MUSCLE STRAIN 3 0.0003
388 HYPERTONIC BLADDER 1 0.0003
389 DYSPNOEA AT REST 1 0.0003
390 DEVICE USE ISSUE 6 0.0003
391 HYPERTRIGLYCERIDAEMIA 2 0.0003
392 NECK INJURY 1 0.0003
393 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
394 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
395 WRONG DRUG ADMINISTERED 3 0.0003
396 FACIAL PAIN 3 0.0003
397 INFUSION SITE REACTION 1 0.0003
398 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
399 CRANIOCEREBRAL INJURY 1 0.0003
400 INGUINAL HERNIA 2 0.0003
401 MENISCUS INJURY 2 0.0003
402 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
403 DIASTOLIC DYSFUNCTION 1 0.0003
404 BLEPHAROSPASM 2 0.0003
405 EXPOSURE TO TOXIC AGENT 1 0.0003
406 LYMPHOCYTE COUNT INCREASED 1 0.0003
407 BREAST ENLARGEMENT 1 0.0003
408 HYPOGAMMAGLOBULINAEMIA 2 0.0003
409 DEAFNESS NEUROSENSORY 1 0.0003
410 LISTLESS 1 0.0003
411 LIGAMENT SPRAIN 3 0.0003
412 PHOTOSENSITIVITY REACTION 5 0.0003
413 LYME DISEASE 1 0.0003
414 BURNING SENSATION 21 0.0003
415 THROAT TIGHTNESS 8 0.0003
416 HEPATIC CYST 1 0.0003
417 EAR DISCOMFORT 3 0.0003
418 EYE MOVEMENT DISORDER 2 0.0003
419 POOR VENOUS ACCESS 3 0.0003
420 CERVICAL VERTEBRAL FRACTURE 1 0.0003
421 LARGE INTESTINE POLYP 2 0.0003
422 MICTURITION DISORDER 1 0.0003
423 HAND FRACTURE 2 0.0003
424 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 57 0.0003
425 SKIN CANCER 6 0.0003
426 DEVICE KINK 1 0.0003
427 FOOD INTOLERANCE 1 0.0003
428 SKIN INFECTION 3 0.0003
429 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
430 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
431 CHRONIC SINUSITIS 1 0.0003
432 CHEMOTHERAPY 1 0.0003
433 IMPAIRED DRIVING ABILITY 3 0.0003
434 THERAPY PARTIAL RESPONDER 4 0.0003
435 CERVIX CARCINOMA 1 0.0003
436 PULMONARY HAEMORRHAGE 2 0.0003
437 NAIL DISCOLOURATION 1 0.0003
438 DISABILITY 5 0.0003
439 SINUS DISORDER 5 0.0003
440 PNEUMOTHORAX 4 0.0003
441 THERAPY INTERRUPTED 18 0.0003
442 OBSTRUCTION 1 0.0003
443 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
444 FRUSTRATION TOLERANCE DECREASED 2 0.0002
445 SWELLING FACE 16 0.0002
446 HYPERAESTHESIA 2 0.0002
447 MUSCLE INJURY 2 0.0002
448 PRODUCT STORAGE ERROR 21 0.0002
449 PRODUCT COMPLAINT 6 0.0002
450 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
451 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
452 IRRITABLE BOWEL SYNDROME 5 0.0002
453 MUSCULOSKELETAL DISCOMFORT 4 0.0002
454 SKIN SWELLING 2 0.0002
455 MELANOCYTIC NAEVUS 1 0.0002
456 SPINAL OSTEOARTHRITIS 2 0.0002
457 IMMUNE SYSTEM DISORDER 3 0.0002
458 HEAD DISCOMFORT 4 0.0002
459 SURGERY 13 0.0002
460 HEAD INJURY 7 0.0002
461 LIMB INJURY 6 0.0002
462 RETINAL DETACHMENT 2 0.0002
463 NEPHROGENIC ANAEMIA 1 0.0002
464 DYSGEUSIA 16 0.0002
465 APHONIA 3 0.0002
466 BLOOD SODIUM DECREASED 4 0.0002
467 FOOT FRACTURE 4 0.0002
468 ENDOMETRIOSIS 1 0.0002
469 HYPOACUSIS 9 0.0002
470 HYPERCHOLESTEROLAEMIA 2 0.0002
471 FINGER DEFORMITY 1 0.0002
472 EAR PAIN 4 0.0002
473 AUTOIMMUNE DISORDER 2 0.0002
474 VITAMIN D DEFICIENCY 2 0.0002
475 HYPERVOLAEMIA 1 0.0002
476 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
477 BLADDER DISORDER 2 0.0002
478 ABDOMINAL TENDERNESS 1 0.0002
479 DRUG TOLERANCE 1 0.0002
480 DRY MOUTH 16 0.0002
481 INSURANCE ISSUE 3 0.0002
482 RIB FRACTURE 4 0.0002
483 LYMPHOMA 3 0.0002
484 ACCIDENTAL EXPOSURE TO PRODUCT 20 0.0002
485 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
486 BASAL CELL CARCINOMA 3 0.0002
487 TENDERNESS 2 0.0002
488 PETECHIAE 2 0.0002
489 BRAIN FOG 3 0.0002
490 TRANSFUSION 2 0.0002
491 GASTRITIS 5 0.0002
492 SCRATCH 2 0.0002
493 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
494 HYPERSENSITIVITY 35 0.0002
495 BODY HEIGHT DECREASED 2 0.0002
496 RHINORRHOEA 12 0.0002
497 BRUXISM 1 0.0002
498 GINGIVITIS 1 0.0002
499 SINUSITIS 19 0.0002
500 PRURITUS GENERALISED 4 0.0002
501 ERYTHEMA 38 0.0002
502 BIPOLAR DISORDER 2 0.0002
503 FAECALOMA 1 0.0002
504 DEAFNESS UNILATERAL 1 0.0002
505 DEVICE DIFFICULT TO USE 12 0.0002
506 VERTIGO 11 0.0002
507 GASTRIC ULCER HAEMORRHAGE 1 0.0002
508 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
509 DRUG INEFFECTIVE 232 0.0002
510 PRODUCT AVAILABILITY ISSUE 4 0.0002
511 SCAB 2 0.0002
512 SCAR 3 0.0002
513 CORONARY ARTERY BYPASS 1 0.0002
514 HERPES VIRUS INFECTION 1 0.0002
515 PRODUCT DOSE OMISSION 11 0.0002
516 THIRST 3 0.0002
517 MIGRAINE 16 0.0002
518 ODYNOPHAGIA 1 0.0002
519 ACCIDENT 2 0.0002
520 MUSCLE RIGIDITY 2 0.0002
521 WRIST FRACTURE 2 0.0002
522 HEARING IMPAIRED 1 0.0002
523 ENDOPHTHALMITIS 1 0.0002
524 TOOTHACHE 3 0.0002
525 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
526 PELVIC PAIN 3 0.0002
527 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
528 INJECTION SITE EXTRAVASATION 2 0.0002
529 BALANCE DISORDER 14 0.0002
530 GENERALISED OEDEMA 2 0.0002
531 NECK PAIN 9 0.0002
532 BACTERIAL INFECTION 3 0.0002
533 INJECTION SITE DISCOLOURATION 2 0.0002
534 SECRETION DISCHARGE 2 0.0002
535 BLOOD URINE PRESENT 3 0.0002
536 MUSCULOSKELETAL DISORDER 3 0.0002
537 PULMONARY FIBROSIS 3 0.0002
538 MYDRIASIS 2 0.0002
539 ROTATOR CUFF SYNDROME 2 0.0002
540 INFUSION SITE PAIN 2 0.0002
541 HIATUS HERNIA 2 0.0002
542 HERPES SIMPLEX 1 0.0002
543 NODULE 2 0.0002
544 DEAFNESS 4 0.0002
545 IMPAIRED HEALING 5 0.0002
546 DYSGRAPHIA 1 0.0002
547 SARS-COV-2 TEST POSITIVE 2 0.0002
548 CORONAVIRUS INFECTION 1 0.0002
549 SPINAL FRACTURE 3 0.0001
550 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
551 UVEITIS 2 0.0001
552 PRODUCT QUALITY ISSUE 20 0.0001
553 ABNORMAL LOSS OF WEIGHT 1 0.0001
554 GASTRIC DISORDER 5 0.0001
555 UNEVALUABLE EVENT 11 0.0001
556 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26 0.0001
557 MASS 2 0.0001
558 KNEE ARTHROPLASTY 3 0.0001
559 HEART RATE DECREASED 5 0.0001
560 BRONCHOSPASM 2 0.0001
561 POOR QUALITY SLEEP 3 0.0001
562 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
563 HEADACHE 86 0.0001
564 INTENTIONAL PRODUCT MISUSE 12 0.0001
565 CHEST DISCOMFORT 14 0.0001
566 ARTHROPOD BITE 1 0.0001
567 FEELING DRUNK 1 0.0001
568 PULMONARY MASS 2 0.0001
569 COLON CANCER 2 0.0001
570 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
571 SNEEZING 3 0.0001
572 THROAT IRRITATION 6 0.0001
573 EPISTAXIS 10 0.0001
574 BREAST TENDERNESS 1 0.0001
575 PRODUCT DOSE OMISSION ISSUE 39 0.0001
576 OFF LABEL USE 116 0.0001
577 OSTEOPENIA 2 0.0001
578 INCORRECT DOSE ADMINISTERED 30 0.0001
579 HIP ARTHROPLASTY 2 0.0001
580 OROPHARYNGEAL PAIN 12 0.0001
581 LIMB DISCOMFORT 4 0.0001
582 MUSCULOSKELETAL CHEST PAIN 2 0.0001
583 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
584 RASH PRURITIC 7 0.0001
585 HYPOALBUMINAEMIA 1 0.0001
586 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
587 ILLNESS 13 0.0001
588 RESPIRATORY TRACT CONGESTION 2 0.0001
589 ULCER 2 0.0001
590 MOVEMENT DISORDER 4 0.0001
591 HIP FRACTURE 4 0.0001
592 NEURALGIA 3 0.0001
593 URINARY TRACT INFECTION 21 0.0001
594 DECUBITUS ULCER 1 0.0001
595 BRONCHITIS 9 0.0001
596 ESCHERICHIA INFECTION 1 0.0001
597 HAIR DISORDER 1 0.0001
598 BREAST CANCER STAGE II 1 0.0001
599 DRY SKIN 16 0.0001
600 GAIT INABILITY 4 0.0001
601 BLOOD PRESSURE INCREASED 18 0.0001
602 CARDIAC OPERATION 1 0.0001
603 EXPOSURE VIA SKIN CONTACT 3 0.0001
604 NEUROPATHY PERIPHERAL 11 0.0001
605 HYSTERECTOMY 1 0.0001
606 NERVOUSNESS 6 0.0001
607 DISCOMFORT 7 0.0001
608 MUSCULAR WEAKNESS 13 0.0001
609 NAIL DISORDER 1 0.0001
610 IMMUNOSUPPRESSION 1 0.0001
611 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
612 GALLBLADDER DISORDER 2 0.0001
613 GASTROINTESTINAL INFECTION 1 0.0001
614 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
615 HEAVY MENSTRUAL BLEEDING 1 0.0001
616 GASTROENTERITIS VIRAL 2 0.0001
617 BONE DISORDER 2 0.0001
618 HIDRADENITIS 1 0.0001
619 EXOSTOSIS 1 0.0001
620 SKIN LESION 3 0.0001
621 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
622 SKIN DISCOLOURATION 5 0.0001
623 NERVE COMPRESSION 1 0.0001
624 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
625 THINKING ABNORMAL 2 0.0001
626 NEPHROPATHY 1 0.0001
627 COUGH 30 0.0001
628 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
629 SKIN EXFOLIATION 9 0.0001
630 PRODUCT USE ISSUE 20 0.0001
631 LACERATION 1 0.0001
632 ARTERIOSCLEROSIS 1 0.0001
633 RASH ERYTHEMATOUS 5 0.0001
634 HERPES ZOSTER 6 0.0001
635 POST PROCEDURAL COMPLICATION 2 0.0001
636 HOSPITALISATION 16 0.0001
637 LOWER LIMB FRACTURE 2 0.0001
638 ATELECTASIS 1 0.0001
639 HERNIA 2 0.0001
640 ERUCTATION 2 0.0001
641 DIZZINESS POSTURAL 1 0.0001
642 DYSPHONIA 6 0.0001
643 HAEMORRHOIDS 2 0.0001
644 ORAL HERPES 2 0.0001
645 SKIN FISSURES 2 0.0001
646 DIZZINESS 51 0.0001
647 LABORATORY TEST ABNORMAL 3 0.0001
648 BODY TEMPERATURE DECREASED 1 0.0001
649 PRURITUS 39 0.0001
650 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
651 BLOOD PRESSURE ABNORMAL 2 0.0001
652 GASTROINTESTINAL DISORDER 9 0.0001
653 UPPER LIMB FRACTURE 2 0.0001
654 THROMBOSIS 8 0.0001
655 FULL BLOOD COUNT DECREASED 2 0.0001
656 FALL 33 0.0001
657 INFLUENZA 11 0.0001
658 DRY THROAT 1 0.0001
659 INJURY ASSOCIATED WITH DEVICE 2 0.0001
660 NEUTROPHIL COUNT INCREASED 1 0.0001
661 EUPHORIC MOOD 1 0.0001
662 COVID-19 17 0.0001
663 INFLAMMATION 5 0.0001
664 SWOLLEN TONGUE 3 0.0001
665 POLLAKIURIA 4 0.0001
666 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
667 MOUTH ULCERATION 2 0.0001
668 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
669 JOINT DISLOCATION 1 0.0001
670 FULL BLOOD COUNT ABNORMAL 1 0.0001
671 OSTEOARTHRITIS 4 0.0001
672 CYSTITIS 3 0.0001
673 BREAST PAIN 1 0.0001
674 HALLUCINATION 7 0.0001
675 DECREASED ACTIVITY 1 0.0001
676 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
677 OEDEMA 5 0.0001
678 CHRONIC KIDNEY DISEASE 7 0.0001
679 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
680 ASPIRATION 1 0.0001
681 BLOOD GLUCOSE FLUCTUATION 1 0.0001
682 GASTROINTESTINAL PAIN 1 0.0001
683 PERIPHERAL SWELLING 14 0.0001
684 MELAENA 2 0.0001
685 APPLICATION SITE PAIN 2 0.0001
686 FOOT DEFORMITY 1 0.0001
687 VIRAL INFECTION 3 0.0001
688 FUNGAL INFECTION 3 0.0001
689 TOOTH DISORDER 2 0.0001
690 NERVE INJURY 1 0.0001
691 NEOPLASM MALIGNANT 6 0.0001
692 RASH PAPULAR 2 0.0001
693 THERAPY NON-RESPONDER 4 0.0001
694 MITRAL VALVE INCOMPETENCE 1 0.0001
695 MYOCARDIAL ISCHAEMIA 1 0.0001
696 NEPHROLITHIASIS 4 0.0001
697 NEOPLASM 1 0.0001
698 LETHARGY 5 0.0001
699 HYPOAESTHESIA 13 0.0001
700 MUSCLE TWITCHING 2 0.0001
701 RASH MACULAR 3 0.0001
702 BLOOD CHOLESTEROL INCREASED 4 0.0001
703 NASAL CONGESTION 5 0.0001
704 PAIN IN EXTREMITY 25 0.0001
705 LYMPHADENOPATHY 3 0.0001
706 COVID-19 PNEUMONIA 1 0.0001
707 SOMNOLENCE 17 0.0001
708 PRODUCT PRESCRIBING ERROR 2 0.0001
709 FATIGUE 65 0.0001
710 BLOOD PRESSURE FLUCTUATION 2 0.0001
711 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
712 IRRITABILITY 5 0.0001
713 CONTUSION 8 0.0001
714 CEREBROVASCULAR ACCIDENT 14 0.0001
715 ADRENAL INSUFFICIENCY 1 0.0001
716 NOCTURIA 1 0.0001
717 UNDERDOSE 6 0.0001
718 CYTOPENIA 1 0.0001
719 NASOPHARYNGITIS 15 0.0001
720 CYST 1 0.0001
721 AGEUSIA 2 0.0001
722 PAIN 49 0.0001
723 DYSPNOEA EXERTIONAL 3 0.0001
724 CELLULITIS 4 0.0001
725 DIARRHOEA 51 0.0001
726 MUSCLE ATROPHY 1 0.0001
727 INSOMNIA 21 0.0001
728 FLUSHING 8 0.0001
729 TREMOR 13 0.0001
730 MALAISE 34 0.0001
731 SKIN ULCER 2 0.0001
732 RESPIRATORY TRACT INFECTION 2 0.0001
733 ECZEMA 4 0.0001
734 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
735 ADVERSE EVENT 7 0.0001
736 ADVERSE REACTION 1 0.0001
737 EAR INFECTION 2 0.0001
738 FEAR 2 0.0001
739 ABDOMINAL PAIN UPPER 15 0.0001
740 ABNORMAL DREAMS 2 0.0001
741 ARTHROPATHY 4 0.0001
742 DEMENTIA 2 0.0001
743 BLISTER 4 0.0001
744 OXYGEN SATURATION DECREASED 4 0.0001
745 BLOOD TEST ABNORMAL 1 0.0001
746 LYMPHOPENIA 1 0.0001
747 PAIN IN JAW 2 0.0001
748 RED BLOOD CELL COUNT DECREASED 2 0.0001
749 SKIN BURNING SENSATION 5 0.0001
750 IMPAIRED QUALITY OF LIFE 1 0.0001
751 INFECTION 10 0.0001
752 HYPERTHYROIDISM 1 0.0001
753 DYSSTASIA 2 0.0001
754 MUSCULOSKELETAL STIFFNESS 6 0.0001
755 PALPITATIONS 8 0.0001
756 BONE PAIN 4 0.0001
757 CHILLS 8 0.0001
758 URINARY INCONTINENCE 2 0.0001
759 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
760 IMMUNODEFICIENCY 1 0.0001
761 ABDOMINAL DISTENSION 7 0.0001
762 NAUSEA 53 0.0001
763 DEVICE ISSUE 6 0.0001
764 BLOOD POTASSIUM DECREASED 2 0.0001
765 ASTHENIA 25 0.0001
766 HYPOAESTHESIA ORAL 1 0.0001
767 ALOPECIA 13 0.0001
768 CORONARY ARTERY DISEASE 2 0.0001
769 SKIN IRRITATION 3 0.0001
770 TINNITUS 3 0.0001
771 EMOTIONAL DISORDER 2 0.0001
772 BACK PAIN 15 0.0001
773 DELUSION 1 0.0001
774 LUNG INFECTION 1 0.0001
775 COGNITIVE DISORDER 3 0.0001
776 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
777 SWELLING 6 0.0001
778 NERVOUS SYSTEM DISORDER 2 0.0001
779 CYANOSIS 1 0.0001
780 DISEASE RECURRENCE 3 0.0001
781 PRODUCTIVE COUGH 3 0.0001
782 HYPOTHYROIDISM 2 0.0001
783 INTERSTITIAL LUNG DISEASE 3 0.0001
784 ASTHMA 7 0.0001
785 BACK DISORDER 1 0.0001
786 AMNESIA 4 0.0001
787 HYPERTENSION 13 0.0001
788 LUNG DISORDER 3 0.0001
789 INFLUENZA LIKE ILLNESS 5 0.0001
790 SEIZURE 7 0.0001
791 HEART RATE INCREASED 6 0.0001
792 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
793 LIP SWELLING 2 0.0001
794 DEHYDRATION 8 0.0001
795 SKIN DISORDER 2 0.0001
796 URINARY RETENTION 2 0.0001
797 RASH 26 0.0001
798 CONSTIPATION 13 0.0001
799 FACE OEDEMA 1 0.0001
800 CONDITION AGGRAVATED 18 0.0001
801 HEMIPARESIS 1 0.0001
802 FLUID RETENTION 3 0.0001
803 HEPATIC ENZYME INCREASED 4 0.0001
804 MEMORY IMPAIRMENT 8 0.0001
805 NIGHTMARE 2 0.0001
806 GAIT DISTURBANCE 11 0.0001
807 LOCAL SWELLING 1 0.0001
808 SPEECH DISORDER 3 0.0001
809 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
810 COLD SWEAT 1 0.0001
811 LYMPHOCYTE COUNT DECREASED 1 0.0001
812 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
813 TACHYCARDIA 5 0.0001
814 GOUT 1 0.0001
815 PNEUMONIA 18 0.0001
816 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
817 ARTHRALGIA 23 0.0001
818 TREATMENT NONCOMPLIANCE 3 0.0001
819 DYSURIA 2 0.0001
820 BLOOD GLUCOSE ABNORMAL 1 0.0001
821 ABDOMINAL DISCOMFORT 9 0.0001
822 MIDDLE INSOMNIA 1 0.0001
823 HOT FLUSH 4 0.0001
824 INTESTINAL OBSTRUCTION 2 0.0001
825 MYALGIA 9 0.0001
826 RHEUMATOID ARTHRITIS 6 0.0001
827 HYPOCALCAEMIA 1 0.0001
828 FRACTURE 1 0.0001
829 COLITIS 2 0.0001
830 ACNE 4 0.0001
831 DYSPHAGIA 5 0.0001
832 DRUG PRESCRIBING ERROR 1 0.0001
833 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
834 DYSTONIA 1 0.0001
835 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
836 KIDNEY INFECTION 1 0.0001
837 MENORRHAGIA 1 0.0001
838 WHEEZING 3 0.0001
839 DISORIENTATION 2 0.0001
840 HAEMATOCRIT DECREASED 1 0.0001
841 HYPOTENSION 10 0.0000
842 CARDIAC FAILURE 4 0.0000
843 STOMATITIS 3 0.0000
844 DEVICE BREAKAGE 2 0.0000
845 OEDEMA PERIPHERAL 6 0.0000
846 DYSKINESIA 2 0.0000
847 MUSCLE SPASMS 9 0.0000
848 BODY TEMPERATURE INCREASED 1 0.0000
849 HAEMOGLOBIN DECREASED 5 0.0000
850 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
851 DRUG DOSE OMISSION 8 0.0000
852 ROAD TRAFFIC ACCIDENT 2 0.0000
853 DERMATITIS 1 0.0000
854 HALLUCINATION, VISUAL 1 0.0000
855 JOINT INJURY 1 0.0000
856 WEIGHT DECREASED 13 0.0000
857 RECTAL HAEMORRHAGE 2 0.0000
858 FAECES DISCOLOURED 1 0.0000
859 DEVICE DISLOCATION 2 0.0000
860 MENTAL DISORDER 2 0.0000
861 FEELING ABNORMAL 11 0.0000
862 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
863 ANXIETY 13 0.0000
864 INFUSION RELATED REACTION 3 0.0000
865 BLOOD PRESSURE DECREASED 3 0.0000
866 SEPSIS 5 0.0000
867 GLOSSODYNIA 1 0.0000
868 PULMONARY OEDEMA 2 0.0000
869 HEART RATE IRREGULAR 1 0.0000
870 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
871 HYPOKALAEMIA 2 0.0000
872 CONFUSIONAL STATE 7 0.0000
873 RENAL DISORDER 2 0.0000
874 SLEEP DISORDER 3 0.0000
875 PULMONARY EMBOLISM 4 0.0000
876 COMA 2 0.0000
877 BLOOD GLUCOSE DECREASED 2 0.0000
878 JOINT SWELLING 5 0.0000
879 LOCALISED INFECTION 1 0.0000
880 FIBROMYALGIA 1 0.0000
881 ATRIAL FIBRILLATION 4 0.0000
882 INJECTION SITE URTICARIA 1 0.0000
883 DYSPNOEA 23 0.0000
884 ABASIA 1 0.0000
885 VOMITING 19 0.0000
886 INJECTION SITE ERYTHEMA 5 0.0000
887 GASTRIC CANCER 1 0.0000
888 DIABETES MELLITUS 3 0.0000
889 INJECTION SITE SWELLING 3 0.0000
890 HYPOPHAGIA 1 0.0000
891 NO ADVERSE EVENT 7 0.0000
892 HAEMATOMA 1 0.0000
893 APPLICATION SITE ERYTHEMA 1 0.0000
894 JOINT STIFFNESS 1 0.0000
895 INJECTION SITE BRUISING 3 0.0000
896 MENSTRUATION IRREGULAR 1 0.0000
897 DRUG EFFECT DECREASED 2 0.0000
898 FREQUENT BOWEL MOVEMENTS 1 0.0000
899 BLOOD BILIRUBIN INCREASED 1 0.0000
900 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
901 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
902 MENTAL STATUS CHANGES 1 0.0000
903 MEDICATION ERROR 2 0.0000
904 FEELING COLD 1 0.0000
905 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
906 HAEMOPTYSIS 1 0.0000
907 URTICARIA 6 0.0000
908 FLATULENCE 2 0.0000
909 INTENTIONAL DOSE OMISSION 1 0.0000
910 HYPERSOMNIA 1 0.0000
911 PRODUCT SUBSTITUTION ISSUE 2 0.0000
912 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
913 NEEDLE ISSUE 1 0.0000
914 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
915 ASCITES 1 0.0000
916 ADVERSE DRUG REACTION 3 0.0000
917 FEELING HOT 2 0.0000
918 INJECTION SITE RASH 1 0.0000
919 DRUG ADMINISTRATION ERROR 1 0.0000
920 CHEST PAIN 6 0.0000
921 FEMUR FRACTURE 1 0.0000
922 CARDIAC DISORDER 3 0.0000
923 DRUG-INDUCED LIVER INJURY 1 0.0000
924 PARAESTHESIA 5 0.0000
925 METABOLIC ACIDOSIS 1 0.0000
926 LOSS OF CONSCIOUSNESS 4 0.0000
927 DRUG INTOLERANCE 3 0.0000
928 HYPERHIDROSIS 4 0.0000
929 NIGHT SWEATS 1 0.0000
930 DEPRESSION 7 0.0000
931 BLOOD CREATININE INCREASED 2 0.0000
932 DYSPEPSIA 3 0.0000
933 DECREASED APPETITE 7 0.0000
934 ABDOMINAL PAIN 7 0.0000
935 INJECTION SITE PRURITUS 2 0.0000
936 NEUTROPENIA 4 0.0000
937 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
938 MOBILITY DECREASED 2 0.0000
939 DRUG EFFECT INCOMPLETE 1 0.0000
940 AGITATION 2 0.0000
941 DYSARTHRIA 1 0.0000
942 PYREXIA 9 0.0000
943 DEATH 22 0.0000
944 DISEASE PROGRESSION 3 0.0000
945 INJECTION SITE HAEMORRHAGE 2 0.0000
946 PROSTATE CANCER 2 0.0000
947 EXTRA DOSE ADMINISTERED 1 0.0000
948 NEUTROPHIL COUNT DECREASED 1 0.0000
949 LUNG NEOPLASM MALIGNANT 1 0.0000
950 CARDIAC ARREST 2 0.0000
951 TREATMENT FAILURE 2 0.0000
952 RENAL IMPAIRMENT 2 0.0000
953 DEVICE LEAKAGE 1 0.0000
954 MYOCARDIAL INFARCTION 4 0.0000
955 RENAL FAILURE 3 0.0000
956 LIVER DISORDER 1 0.0000
957 COLITIS ULCERATIVE 1 0.0000
958 WEIGHT INCREASED 5 0.0000
959 BREAST CANCER 2 0.0000
960 ARRHYTHMIA 1 0.0000
961 MULTIPLE SCLEROSIS 1 0.0000
962 HYPOGLYCAEMIA 1 0.0000
963 LEUKOPENIA 1 0.0000
964 SYNCOPE 2 0.0000
965 AGGRESSION 1 0.0000
966 HAEMORRHAGE 2 0.0000
967 DEPRESSED MOOD 1 0.0000
968 BRADYCARDIA 1 0.0000
969 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
970 PLATELET COUNT DECREASED 2 0.0000
971 DISTURBANCE IN ATTENTION 1 0.0000
972 HAEMATOCHEZIA 1 0.0000
973 EMOTIONAL DISTRESS 2 0.0000
974 ILL-DEFINED DISORDER 1 0.0000
975 INJECTION SITE PAIN 5 0.0000
976 BLOOD GLUCOSE INCREASED 3 0.0000
977 ANAEMIA 3 0.0000
978 FEBRILE NEUTROPENIA 1 0.0000
979 INJECTION SITE REACTION 1 0.0000
980 INJURY 1 0.0000
981 DRUG INTERACTION 2 0.0000
982 MALIGNANT NEOPLASM PROGRESSION 1 0.0000